Doctors are trying to identify the characteristics that predict which patients aren’t likely to be successful with a catheter ablation for their atrial fibrillation. At a session at the recent Heart Rhythm Society annual meeting, some of the factors discussed included left atrial size, left atrial volume, left ventricle dysfunction (improper functioning of the left …
Read More
An important session at Heart Rhythm Society 2010 was "Medical Issues After Ablation for Atrial Fibrillation and Flutter." It dealt with what constitutes success following catheter ablation for atrial fibrillation (afib) and atrial flutter, and which is more important, the medical definition or the patient's definition. Which definition is used can have implications for treatment …
Read More
In this video interview, Dr. Nassir Marrouche, Executive Director of the Comprehensive Arrhythmia Research and Management (CARMA) Center at the University of Utah Health System, discusses the findings he recently presented at the Heart Rhythm Society annual meeting in Denver. He discussed the intriguing way they are using MRI (magnetic resonance imaging), to personalize atrial …
Read More
At Heart Rhythm Society 2010, we saw intriguing new research into personalized afib treatment and stroke prevention that was presented by Dr. Nassir Marrouche and Dr. Marcos Daccarett of the Comprehensive Arrhythmia Research and Management (CARMA) Center at the University of Utah Health System. They have developed a way, using MRI (magnetic resonance imaging), to …
Read More
In preparation for the upcoming free community Atrial Fibrillation Seminar in Salt Lake City on Wednesday, May 19, renowned electrophysiologist Dr. Nassir Marrouche, the executive director of the University of Utah’s Comprehensive Arrhythmia Research & Management (CARMA) center, and Mellanie True Hills, founder of StopAfib.org, talked with NPR about heart disease and atrial fibrillation. Find …
Read More
In this video interview at Boston Atrial Fibrillation Symposium, Dr. Peter Kowey, President of the Main Line Health Heart Center, talked about a number of exciting new things in the atrial fibrillation world. His topics included the Cabana clinical trials, the Safari catheter ablation registry, dronedarone as a replacement for amiodarone, atrial selective drugs, and …
Read More
New research from Dr. Andrea Natale and colleagues on gender disparities in atrial fibrillation points out that women with afib are less likely to have catheter ablation treatment than men. When they do have atrial fibrillation catheter ablations, they tend to be older and sicker, meaning that they are more likely to have persistent or …
Read More
Important new research from the STOP AF Study of people with paroxysmal atrial fibrillation (AF) shows a type of catheter ablation called cryoablation worked better than drugs to control arrhythmias. One year after treatment, 69.9% of people treated with cryoablation had no episodes of afib compared to 7.3% of those who were treated with anti-arrhythmic …
Read More
At Boston Atrial Fibrillation Symposium 2010, Dr. Andrea Russo talked about gender differences in atrial fibrillation treatment, including catheter ablation, as well as women and the risk of stroke from afib. Watch the video: Interview with Dr. Andrea Russo at Boston Atrial Fibrillation Symposium 2010
Read More
At Boston Atrial Fibrillation Symposium 2010, Dr. Riccardo Cappato talked about the impact of atrial fibrillation on competitive and professional athletes and how catheter ablation for afib has allowed many to return to training and competition. Watch the video, or read the transcript: Dr. Riccardo Cappato Part 2: Discussion of Athletes and Atrial Fibrillation
Read More